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Background
In an attempt to raise protective antiviral immunity,
dendritic cell (DC) immunotherapy was evaluated in 6
adults infected with human immunodeficiency virus
(HIV)-1 and stable under antiretroviral therapy
(HAART).
Methods
Autologous monocyte-derived DC electroporated with
mRNA encoding Gag and TatRevNef fusion protein
were injected 4 times at 4 weeks interval, while patients
remained on HAART. Feasibility, safety and immuno-
genicity were investigated.
Results
DC vaccine preparation and administration was success-
ful in all patients and only mild adverse events such as
skin reactions were seen. DC vaccination induced
immune responses that have been reported to be related
to control of HIV-1 replication. There was a significant
increase post-as compared to pre-DC vaccination, in
magnitude - in particular to Gag – and breadth of HIV-
1-specific interferon (IFN)-g response and T-cell prolif-
eration. Breadth of IFN-g response and T-cell prolifera-
tion were correlated with both CD4+ and CD8+
polyfunctional T-cell responses. Importantly, DC vacci-
nation induced or increased the capacity of autologous
CD8+ T-cells to suppress superinfection of CD4+ T-
cells with the vaccine-related IIIB virus and to a lesser
extent with other HIV-1 strains. This CD8+ T-cell-
mediated HIV-1-inhibitory activity was correlated with
increased breadth of Gag-specific IFN-g response, indi-
cative of improved control of HIV replication. These
features are indicative of improved virus control.
Conclusion
Therapeutic immunization of patients stable under
HAART with DC electroporated with mRNA encoding
HIV-1 antigens is safe and was successful in raising anti-
viral cellular immune responses, including effector CD8
+T-cells with inhibitory activity towards infection of
CD4+T-cells with a vaccine-homologous HIV strain.
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